Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
2.

The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.

Geldsetzer P, Manne-Goehler J, Marcus ME, Ebert C, Zhumadilov Z, Wesseh CS, Tsabedze L, Supiyev A, Sturua L, Bahendeka SK, Sibai AM, Quesnel-Crooks S, Norov B, Mwangi KJ, Mwalim O, Wong-McClure R, Mayige MT, Martins JS, Lunet N, Labadarios D, Karki KB, Kagaruki GB, Jorgensen JMA, Hwalla NC, Houinato D, Houehanou C, Msaidié M, Guwatudde D, Gurung MS, Gathecha G, Dorobantu M, Damasceno A, Bovet P, Bicaba BW, Aryal KK, Andall-Brereton G, Agoudavi K, Stokes A, Davies JI, Bärnighausen T, Atun R, Vollmer S, Jaacks LM.

Lancet. 2019 Jul 18. pii: S0140-6736(19)30955-9. doi: 10.1016/S0140-6736(19)30955-9. [Epub ahead of print]

PMID:
31327566
3.

Left Atrial Strain for Predicting Atrial Fibrillation Onset in Hypertensive Patients.

Petre I, Onciul S, Iancovici S, Zamfir D, Stoian M, Scărlătescu A, Diaconeasa A, Acatrinei C, Dorobanțu M.

High Blood Press Cardiovasc Prev. 2019 Aug;26(4):331-337. doi: 10.1007/s40292-019-00326-4. Epub 2019 Jul 15.

PMID:
31309456
4.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Jul 29;:.

PMID:
31272931
5.

Exploring the Continuum of Hypertrophic Cardiomyopathy-From DNA to Clinical Expression.

Popa-Fotea NM, Micheu MM, Bataila V, Scafa-Udriste A, Dorobantu L, Scarlatescu AI, Zamfir D, Stoian M, Onciul S, Dorobantu M.

Medicina (Kaunas). 2019 Jun 23;55(6). pii: E299. doi: 10.3390/medicina55060299. Review.

6.

Rising rural body-mass index is the main driver of the global obesity epidemic in adults.

NCD Risk Factor Collaboration (NCD-RisC).

Nature. 2019 May;569(7755):260-264. doi: 10.1038/s41586-019-1171-x. Epub 2019 May 8.

7.

May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.

Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ, Schlaich MP, Schutte AE, Tomaszewski M, Touyz R, Wang JG, Weber MA, Poulter NR; MMM Investigators .

Eur Heart J. 2019 Jul 1;40(25):2006-2017. doi: 10.1093/eurheartj/ehz300.

8.

The Association Between Six Surrogate Insulin Resistance Indexes and Hypertension: A Population-Based Study.

Bala C, Gheorghe-Fronea O, Pop D, Pop C, Caloian B, Comsa H, Bozan C, Matei C, Dorobantu M.

Metab Syndr Relat Disord. 2019 Jul/Aug;17(6):328-333. doi: 10.1089/met.2018.0122. Epub 2019 Apr 29.

PMID:
31034338
9.

The Attitude of Patients from a Romanian Tertiary Cardiology Center as Regards Participation in Biomarker-Based Clinical Trials - Survey Methodology.

Mihaela Micheu M, Udrea OM, Octavia Popa M, Rusu I, Gheorghe-Fronea O, Scafa-Udriste A, Dorobantu M.

J Med Life. 2018 Oct-Dec;11(4):320-327. doi: 10.25122/jml-2018-0072.

10.

Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys.

Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, Bovet P, Brian G, Dorobantu M, Gathecha G, Singh Gurung M, Guwatudde D, Msaidie M, Houehanou C, Houinato D, Jorgensen JMA, Kagaruki GB, Karki KB, Labadarios D, Martins JS, Mayige MT, McClure RW, Mwalim O, Mwangi JK, Norov B, Quesnel-Crooks S, Silver BK, Sturua L, Tsabedze L, Wesseh CS, Stokes A, Marcus M, Ebert C, Davies JI, Vollmer S, Atun R, Bärnighausen TW, Jaacks LM.

PLoS Med. 2019 Mar 1;16(3):e1002751. doi: 10.1371/journal.pmed.1002751. eCollection 2019 Mar.

11.

Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.

Vaccarino V, Badimon L, Bremner JD, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Koller A, Manfrini O, Milicic D, Padro T, Pries AR, Quyyumi AA, Tousoulis D, Trifunovic D, Vasiljevic Z, de Wit C, Bugiardini R; ESC Scientific Document Group Reviewers .

Eur Heart J. 2019 Jan 28. doi: 10.1093/eurheartj/ehy913. [Epub ahead of print] No abstract available.

PMID:
30698764
12.

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.

Parati G, Agabiti-Rosei E, Bakris GL, Bilo G, Branzi G, Cecchi F, Chrostowska M, De la Sierra A, Domenech M, Dorobantu M, Faria T, Huo Y, Jelaković B, Kahan T, Konradi A, Laurent S, Li N, Madan K, Mancia G, McManus RJ, Modesti PA, Ochoa JE, Octavio JA, Omboni S, Palatini P, Park JB, Pellegrini D, Perl S, Podoleanu C, Pucci G, Redon J, Renna N, Rhee MY, Rodilla Sala E, Sanchez R, Schmieder R, Soranna D, Stergiou G, Stojanovic M, Tsioufis K, Valsecchi MG, Veglio F, Waisman GD, Wang JG, Wijnmaalen P, Zambon A, Zanchetti A, Zhang Y.

BMJ Open. 2018 Dec 19;8(12):e021038. doi: 10.1136/bmjopen-2017-021038.

13.

The Winding Road of Cardiac Regeneration-Stem Cell Omics in the Spotlight.

Micheu MM, Scarlatescu AI, Scafa-Udriste A, Dorobantu M.

Cells. 2018 Dec 7;7(12). pii: E255. doi: 10.3390/cells7120255. Review.

14.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
15.

The Relationship Between Psychosocial Status and Hypertensive Condition.

Matei Ș, Cutler SJ, Preda M, Dorobanțu M, Ilinca C, Gheorghe-Fronea O, Rădulescu L, Oprescu N, Deaconu A, Zorilă C, Dorobanțu B.

Curr Hypertens Rep. 2018 Oct 25;20(12):102. doi: 10.1007/s11906-018-0902-y. Review.

PMID:
30361797
16.

Arterial stiffness mediates the effect of salt intake on systolic blood pressure.

Siriopol D, Covic A, Iliescu R, Kanbay M, Tautu O, Radulescu L, Mitu O, Salaru D, Dorobantu M.

J Clin Hypertens (Greenwich). 2018 Nov;20(11):1587-1594. doi: 10.1111/jch.13399. Epub 2018 Oct 7.

17.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. No abstract available.

PMID:
30165516
18.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

19.

Serum uric acid and arterial hypertension-Data from Sephar III survey.

Buzas R, Tautu OF, Dorobantu M, Ivan V, Lighezan D.

PLoS One. 2018 Jul 2;13(7):e0199865. doi: 10.1371/journal.pone.0199865. eCollection 2018.

20.

Microvascular (dys)Function in Stable Coronary Artery Disease: Cross Talk with Epicardial Segments.

Calmac L, Bataila V, Dragoescu B, Mihai C, Scafa-Udriste A, Dorobantu M.

Curr Pharm Des. 2018;24(25):2900-2905. doi: 10.2174/1381612824666180702113448.

PMID:
29962337

Supplemental Content

Loading ...
Support Center